Uterine Corpus Carcinoma

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS research · 2026-04-13
Clinical Trial Update: Testing the Combination of APG-1252 (Pelcitoclax) and Cobimetinib in Recurrent Ovarian and Endometrial Cancers [Phase 1]
This is a Phase 1 clinical trial update evaluating the combination of APG-1252 (Pelcitoclax) and cobimetinib in recurrent and advanced ovari…